News

A comparison of synthetic gene-activating Cas9 proteins can help guide research and development of therapeutic approaches.

Researchers at The University of Texas at Austin demonstrated the ability to detect single viruses in a solution containing murine cytomegalovirus (MCMV).

Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.

New Phenome Centre Birmingham, UK to use Thermo Scientific mass spectrometry instruments to advance metabolic phenotyping and metabolomics studies.

Scripps scientists have designed a drug candidate that decreases growth of breast cancer cells.

Company has announced that Janssen Research and Development has signed an agreement to license Optibrium’s StarDrop software.

Evotec and Genentech will continue their drug discovery alliance for a further three years.

Launch of first joint product – VEGF 165 for cell culture applications.

A special type of microalgae can soon produce valuable chemicals such as cancer treatment drugs and much more just by harnessing energy from the sun.

In response to further market speculation and stakeholder inquiries, Bayer is publicly disclosing the contents of its private proposal to acquire Monsanto.